Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.

Currently, chronic traumatic encephalopathy can only be diagnosed post-mortem via brain tissue assessment during an autopsy.

A news release indicates the suspensions are due to breast images not meeting the college's clinical quality standards. 

Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.

See What’s New:

Radiologists who experienced a practice closure are more likely to operate as subspecialists afterward, according to new Neiman research.  

Meanwhile, the Amsterdam-based imaging giant said it has already taken action to begin correcting these issues. 

The society's board has selected Suhny Abbara, MD, to take on the prestigious title in January following an “extensive” international search. 

The company is working to commercialize MK-6240, a radiodiagnostic that targets tau protein tangles—a “key hallmark of several neurodegenerative diseases.” 

This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.